KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Gains from Sales and Divestitures (2017 - 2024)

Historic Gains from Sales and Divestitures for Fulgent Genetics (FLGT) over the last 8 years, with Q4 2024 value amounting to $1.0 million.

  • Fulgent Genetics' Gains from Sales and Divestitures fell 581.61% to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year decrease of 581.61%. This contributed to the annual value of $1.0 million for FY2024, which is 581.61% down from last year.
  • Fulgent Genetics' Gains from Sales and Divestitures amounted to $1.0 million in Q4 2024, which was down 581.61% from $1.1 million recorded in Q4 2023.
  • In the past 5 years, Fulgent Genetics' Gains from Sales and Divestitures ranged from a high of $1.1 million in Q4 2023 and a low of $655000.0 during Q4 2020
  • Its 5-year average for Gains from Sales and Divestitures is $852000.0, with a median of $836000.0 in 2021.
  • Per our database at Business Quant, Fulgent Genetics' Gains from Sales and Divestitures tumbled by 1638.76% in 2022 and then surged by 5250.36% in 2023.
  • Quarter analysis of 5 years shows Fulgent Genetics' Gains from Sales and Divestitures stood at $655000.0 in 2020, then rose by 27.63% to $836000.0 in 2021, then dropped by 16.39% to $699000.0 in 2022, then skyrocketed by 52.5% to $1.1 million in 2023, then dropped by 5.82% to $1.0 million in 2024.
  • Its last three reported values are $1.0 million in Q4 2024, $1.1 million for Q4 2023, and $699000.0 during Q4 2022.